Filing Details
- Accession Number:
- 0001225208-17-013378
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-08 17:02:03
- Reporting Period:
- 2017-08-04
- Filing Date:
- 2017-08-08
- Accepted Time:
- 2017-08-08 17:02:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 78003 | Pfizer Inc | PFE | Pharmaceutical Preparations (2834) | 135315170 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1372915 | C Ian Read | Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017 | Chairman & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-08-04 | 28,116 | $34.00 | 636,293 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-08-04 | 68,834 | $34.00 | 221,955 | No | 4 | S | Indirect | By Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Trust |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 10,776 | Indirect | By Rule 16b-3 Plan |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 5, 2017.
- In accordance with the provisions of his Grantor Retained Annuity Trust (GRAT), 119,973 shares were transferred from the GRAT to the reporting person's direct ownership on March 16, 2017.
Billionaire Hedge Funds
